These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S, Club de Réflexion sur les Infections en Onco-Hématologie. Clin Infect Dis; 2003 Jan 15; 36(2):149-58. PubMed ID: 12522746 [Abstract] [Full Text] [Related]
9. [A new antibiotic in the treatment of infections caused by gram positive bacteria: lincomycin. In vitro study and clinical experience]. Bertrand A, Janbon F. Sem Hop; 1967 Dec 08; 43(51):3263-6. PubMed ID: 4299182 [No Abstract] [Full Text] [Related]
19. Antimicrobial resistance. Guidelines for the primary care physician. Williams DN. Minn Med; 1998 May 08; 81(5):25-9. PubMed ID: 9637855 [Abstract] [Full Text] [Related]
20. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias]. Hernández Martí V, Romá Sánchez E, Salavert Lletí M, Bosó Ribelles V, Poveda Andrés JL. Rev Esp Quimioter; 2007 Sep 08; 20(3):261-76. PubMed ID: 18080024 [Abstract] [Full Text] [Related] Page: [Next] [New Search]